ATE269099T1 - Bpi-protein-produkte für definierte funktionen des reticuloendothelialen systems - Google Patents

Bpi-protein-produkte für definierte funktionen des reticuloendothelialen systems

Info

Publication number
ATE269099T1
ATE269099T1 AT94930656T AT94930656T ATE269099T1 AT E269099 T1 ATE269099 T1 AT E269099T1 AT 94930656 T AT94930656 T AT 94930656T AT 94930656 T AT94930656 T AT 94930656T AT E269099 T1 ATE269099 T1 AT E269099T1
Authority
AT
Austria
Prior art keywords
reticuloendothelial system
bpi protein
protein products
defined functions
system function
Prior art date
Application number
AT94930656T
Other languages
English (en)
Inventor
Leeuwen Paul A M Van
Marja A Boermeester
Original Assignee
Xoma Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xoma Technology Ltd filed Critical Xoma Technology Ltd
Application granted granted Critical
Publication of ATE269099T1 publication Critical patent/ATE269099T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4742—Bactericidal/Permeability-increasing protein [BPI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT94930656T 1993-10-15 1994-10-05 Bpi-protein-produkte für definierte funktionen des reticuloendothelialen systems ATE269099T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13251093A 1993-10-15 1993-10-15
PCT/US1994/011404 WO1995010297A1 (en) 1993-10-15 1994-10-05 Method of treating depressed reticuloendothelial system function

Publications (1)

Publication Number Publication Date
ATE269099T1 true ATE269099T1 (de) 2004-07-15

Family

ID=22454373

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94930656T ATE269099T1 (de) 1993-10-15 1994-10-05 Bpi-protein-produkte für definierte funktionen des reticuloendothelialen systems

Country Status (7)

Country Link
EP (1) EP0722333B1 (de)
AT (1) ATE269099T1 (de)
AU (1) AU7970894A (de)
CA (1) CA2173611C (de)
DE (1) DE69433848T2 (de)
WO (1) WO1995010297A1 (de)
ZA (1) ZA947783B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652332A (en) * 1993-03-12 1997-07-29 Xoma Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
US5643875A (en) * 1994-01-24 1997-07-01 Friedmann; Nadav Human therapeutic uses of bactericidal/permeability increasing (BPI) protein products
US5447913A (en) 1994-03-11 1995-09-05 Xoma Corporation Therapeutic uses of bactericidal/permeability-increasing protein dimer products
WO1997004008A1 (en) * 1995-07-20 1997-02-06 Xoma Corporation Anti-fungal peptides
ES2153665T3 (es) 1996-05-10 2001-03-01 Xoma Technology Ltd Usos terapeuticos de productos proteicos bactericidas/incrementadores de la permeabilidad (bpi) para la meningococemia humana.
US5741779A (en) 1996-05-10 1998-04-21 Xoma Corporation Antithrombotic materials and methods
NZ332954A (en) * 1996-05-23 2000-07-28 Xoma Corp Use of BPI protein products to treat humans with hemorrhage due to trauma
US5888973A (en) * 1996-08-09 1999-03-30 Xoma Corporation Anti-chlamydial uses of BPI protein products
US6482796B2 (en) 1996-11-01 2002-11-19 Xoma Corporation Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients
US6093573A (en) * 1997-06-20 2000-07-25 Xoma Three-dimensional structure of bactericidal/permeability-increasing protein (BPI)
US6013631A (en) * 1998-06-19 2000-01-11 Xoma Corporation Bactericidal/permeability-increasing protein (BPI) deletion analogs
EP1741440A1 (de) 2005-07-08 2007-01-10 Mellitus S.L. Verwendung von BPI-proteine zur Behandlung von stoffwechselbedingten Erkrankungen und Herzkreislaufstörungen
GB0803352D0 (en) 2008-02-22 2008-04-02 Ntnu Technology Transfer As Oligopeptidic compounds and uses thereof
GB201319620D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Immunosuppressive agents and their use in therapy
GB201319621D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Antimicrobial agents and their use in therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171739A (en) * 1989-02-14 1992-12-15 Incyte Pharmaceuticals, Inc. Treatment of endotoxin-associated shock and preventation thereof using a BPI protein
US5234912A (en) * 1989-02-14 1993-08-10 Incyte Pharmaceuticals, Inc. Pharmaceutical compositions comprising recombinant BPI proteins and a lipid carrier and uses thereof
JP4139863B2 (ja) * 1993-03-12 2008-08-27 ゾーマ テクノロジー リミテッド 殺菌性／透過性が向上したタンパク質の機能領域に由来する生物学的に活性なペプチドおよびその使用

Also Published As

Publication number Publication date
ZA947783B (en) 1996-05-05
DE69433848T2 (de) 2005-05-25
EP0722333A1 (de) 1996-07-24
CA2173611A1 (en) 1995-04-20
HK1014498A1 (en) 1999-09-30
AU7970894A (en) 1995-05-04
WO1995010297A1 (en) 1995-04-20
CA2173611C (en) 2005-07-26
EP0722333B1 (de) 2004-06-16
DE69433848D1 (de) 2004-07-22

Similar Documents

Publication Publication Date Title
DE69433848D1 (de) Bpi-protein-produkte für definierte funktionen des reticuloendothelialen systems
MX9602570A (es) Metodos y materiales anti-fungosos.
EP0749080A3 (de) System zum Vewalten von Bestellungen
ES2119185T3 (es) Tratamiento de enfermedades micobacterianas por administracion de productos de la proteina bactericida/que aumenta la permeabilidad.
DE69727142D1 (de) Verwendung eines bpi proteinproduktes als antithrombotisches mittel
ZA969130B (en) Diagnostics and treatments of periodontal disease
ZA955740B (en) Anti-protozoan methods and materials
DK0845998T3 (da) Lægemidler til immunbehandling indeholdende antistoffer, der specifikt genkender MHCII-antigenet hos en patient, der skal behandles
ATE226442T1 (de) Anti-chlamydia verfahren und mittel
MX9602442A (es) Un tratamiento con fluoroquinolona a dosis unica elevada.
ATE207079T1 (de) Produkt aus von beta-cesein wesentlich freier milch aus nicht-menschlichen sängetieren und dessen verwendung
MY113431A (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
DE69528820D1 (de) Verwendung von Zahnpflegemitteln enthaltend bovines Kolostrum
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
PL328948A1 (en) Autism treating method
ATE259242T1 (de) Cd4-derivierte peptide die einen immunrespons inhibieren
AU653332B2 (en) Synthetic peptides which contain sequences from factor VIIa, and the use thereof
TR199901998T2 (xx) 9,10-sekokolesta-5,7,10(19)-triyen-1,3-diyol veya alfakasidol�n kullan�m�.
PT741746E (pt) Compostos sinteticos relacionados com a timosina alfa1 e novos metodos para a sua sintese
DE59610098D1 (de) Protein mit anti-tumorwirkung
UA8333A1 (uk) Спосіб лікування септичних захворювань
UA43389C2 (uk) Спосіб зниження рівнів кальцію у сироватці
UA10259A (uk) Протинабряковий лікарський препарат "нейрополіосм"

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties